Ad is loading...
MENU
INTI
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Inhibitor Therapeutics (INTI) Ownership - Who owns Inhibitor Therapeutics?

Profile

Industry
N/A
Address
4905 South West Shore Boulevard
Phone
+1 813 864-2562
Employees
9
Web
https://www.inhibitortx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.79M
P/E Ratio
N/A
Total Cash
7.1M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.68
Dividend Yield
N/A
Total Cash/Share
0.04
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

INTI
Capitalization
13.8M
P/E Ratio
N/A
Risk (Beta)
-0.68
Dividend Yield
N/A
Total Cash
7.1M
Total Cash/Share
0.04
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.14M
P/B Ratio
3.33
Cash Flow
N/A
Earnings
-0.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.2K
Current Ratio
201.91
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-3.01M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.83
Shares Held By Institutions
0
Shares Outstanding - Current
172M
Total Liabilities
3.04M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-13.043
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4905 South West Shore Boulevard
Phone
+1 813 864-2562
Employees
9
Web
https://www.inhibitortx.com